Zhiguo Li
- Cancer Research top 10%
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis 5
- Cancer Treatment and Pharmacology 4
- Cancer Cells and Metastasis 3
-
- Gastric Cancer Management and Outcomes 7
- Lung Cancer Treatments and Mutations 3
-
- Antiplatelet Therapy and Cardiovascular Diseases 4
- Atrial Fibrillation Management and Outcomes 3
-
- Esophageal Cancer Research and Treatment 3
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Blood (2 papers)Biochemistry (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Zhiguo Li
52 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 102
- Cancer Research 294
- Oncology 457
- Immunology 203
- Pulmonary and Respiratory Medicine 241
- Molecular Biology 455
Countries citing papers authored by Zhiguo Li
This map shows the geographic impact of Zhiguo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiguo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiguo Li more than expected).
Fields of papers citing papers by Zhiguo Li
This network shows the impact of papers produced by Zhiguo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiguo Li. The network helps show where Zhiguo Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhiguo Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 15 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 4 | |
| 5 | 2021 | 5 | |
| 6 | 2020 | 1 | |
| 7 | 2020 | 116 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 33 | |
| 10 | 2019 | 1 | |
| 11 | 2019 | 220 | |
| 12 | 2019 | 23 | |
| 13 | 2018 | 1 | |
| 14 | 2017 | 43 | |
| 15 | 2017 | 105 | |
| 16 | 2014 | 20 | |
| 17 | 2013 | 8 | |
| 18 | 2012 | 31 | |
| 19 | 2011 | 11 | |
| 20 | 2009 | 20 |
About Zhiguo Li
Zhiguo Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 54 papers that have together received 1.2k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (7 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Cancer Treatment and Pharmacology (4 papers), Atrial Fibrillation Management and Outcomes (3 papers), Esophageal Cancer Research and Treatment (3 papers), Cancer Cells and Metastasis (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Cancer Research (294 citations), Oncology (457 citations) and Immunology (203 citations). Zhiguo Li has collaborated with scholars based in China, United States and India. Frequent co-authors include Yingwei Xue, Chunfeng Li, Yimin Wang, Wenpeng Wang, Hongfeng Zhang, Sen Li, Shubin Song, Xiuwen Lan, Xiliang Cong and Yuzhou Zhao. Their work appears in journals such as Blood, Biochemistry and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.